SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
SEC Accession No. 0001193805-20-001255
Filing Date
2020-10-06
Accepted
2020-10-06 16:10:43
Documents
5
Effectiveness Date
2020-10-06

Document Format Files

Seq Description Document Type Size
1 e619966_f6ef-mereo.htm F-6EF 55329
2 e619966_ex99-a.htm EX-99.(A) 453547
3 e619966_ex99-d.htm EX-99.(D) 5894
4 e619966_ex99-e.htm EX-99.(E) 3307
5 GRAPHIC logo.jpg GRAPHIC 18700
  Complete submission text file 0001193805-20-001255.txt   545483
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6EF

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Subject) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6EF | Act: 33 | File No.: 333-249338 | Film No.: 201226889
SIC: 2834 Pharmaceutical Preparations